BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34056907)

  • 1. Combined Metabolomics with Transcriptomics Reveals Important Serum Biomarkers Correlated with Lung Cancer Proliferation through a Calcium Signaling Pathway.
    Zheng Y; He Z; Kong Y; Huang X; Zhu W; Liu Z; Gong L
    J Proteome Res; 2021 Jul; 20(7):3444-3454. PubMed ID: 34056907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined metabolomics with transcriptomics reveals potential plasma biomarkers correlated with non-small-cell lung cancer proliferation through the Akt pathway.
    Zheng J; Zheng Y; Li W; Zhi J; Huang X; Zhu W; Liu Z; Gong L
    Clin Chim Acta; 2022 May; 530():66-73. PubMed ID: 35245482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GC-MS-based metabolomics reveals new biomarkers to assist the differentiation of prostate cancer and benign prostatic hyperplasia.
    Wang W; He Z; Kong Y; Liu Z; Gong L
    Clin Chim Acta; 2021 Aug; 519():10-17. PubMed ID: 33831421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into osteoarthritis through integrative analysis of metabolomics and transcriptomics.
    Huang Z; He Z; Kong Y; Liu Z; Gong L
    Clin Chim Acta; 2020 Nov; 510():323-329. PubMed ID: 32653484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput Salivary Metabolite Profiling on an Ultralow Noise Tip-Enhanced Laser Desorption Ionization Mass Spectrometry Platform for Noninvasive Diagnosis of Early Lung Cancer.
    Jiang X; Chen X; Chen Z; Yu J; Lou H; Wu J
    J Proteome Res; 2021 Sep; 20(9):4346-4356. PubMed ID: 34342461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum untargeted metabolomics reveal metabolic alteration of non-small cell lung cancer and refine disease detection.
    Li J; Liu K; Ji Z; Wang Y; Yin T; Long T; Shen Y; Cheng L
    Cancer Sci; 2023 Feb; 114(2):680-689. PubMed ID: 36310111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker identification and pathway analysis of rheumatoid arthritis based on metabolomics in combination with ingenuity pathway analysis.
    He Z; Liu Z; Gong L
    Proteomics; 2021 Jun; 21(11-12):e2100037. PubMed ID: 33969925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer.
    Xiong Y; Shi C; Zhong F; Liu X; Yang P
    Clin Chim Acta; 2020 Jul; 506():214-221. PubMed ID: 32243985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
    Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
    J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UPLC-MS-Based Serum Metabolic Profiling Reveals Potential Biomarkers for Predicting Propofol Responsiveness in Females.
    Li R; Yang L; Guan S; Lin M; Lai H; Liu K; Liu Z; Zhang X
    J Proteome Res; 2021 Sep; 20(9):4578-4588. PubMed ID: 34384217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic study of serum, urine and bronchoalveolar lavage fluid based on gas chromatography mass spectrometry to delve into the pathology of lung cancer.
    Callejón-Leblic B; García-Barrera T; Pereira-Vega A; Gómez-Ariza JL
    J Pharm Biomed Anal; 2019 Jan; 163():122-129. PubMed ID: 30292984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High resolution metabolomics to discriminate compounds in serum of male lung cancer patients in South Korea.
    Pamungkas AD; Park C; Lee S; Jee SH; Park YH
    Respir Res; 2016 Aug; 17(1):100. PubMed ID: 27506545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in lung cancer biomarkers: The role of (metal-) metabolites and selenoproteins.
    Callejón-Leblic B; Arias-Borrego A; Rodríguez-Moro G; Navarro Roldán F; Pereira-Vega A; Gómez-Ariza JL; García-Barrera T
    Adv Clin Chem; 2021; 100():91-137. PubMed ID: 33453868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid Chromatography-Mass Spectrometry-Based Tissue Metabolic Profiling Reveals Major Metabolic Pathway Alterations and Potential Biomarkers of Lung Cancer.
    You L; Fan Y; Liu X; Shao S; Guo L; Noreldeen HAA; Li Z; Ouyang Y; Li E; Pan X; Liu T; Tian X; Ye F; Li X; Xu G
    J Proteome Res; 2020 Sep; 19(9):3750-3760. PubMed ID: 32693607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform.
    Zhang H; Wang L; Hou Z; Ma H; Mamtimin B; Hasim A; Sheyhidin I
    Biochem Biophys Res Commun; 2017 Sep; 491(1):119-125. PubMed ID: 28711496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential metabolomic biomarkers for reliable diagnosis of Behcet's disease using gas chromatography/ time-of-flight-mass spectrometry.
    Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
    Joint Bone Spine; 2018 May; 85(3):337-343. PubMed ID: 28549946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive analysis of metabolomics and transcriptomics reveals new biomarkers and mechanistic insights on DEHP exposures in MCF-7 cells.
    Lu YS; Yao GX; Wang XL; Liu JX; Yu J; Qiu J; Li Y; Qian YZ; Xu YY
    Chemosphere; 2020 Sep; 255():126865. PubMed ID: 32402870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma.
    Sato T; Kawasaki Y; Maekawa M; Takasaki S; Saigusa D; Ota H; Shimada S; Yamashita S; Mitsuzuka K; Yamaguchi H; Ito A; Kinoshita K; Koshiba S; Mano N; Arai Y
    Int J Cancer; 2019 Jul; 145(2):484-493. PubMed ID: 30628065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the molecular mechanism and diagnostic biomarkers in the thoracic ossification of the ligamentum flavum using metabolomics and transcriptomics.
    Li J; Yu L; Guo S; Zhao Y
    BMC Mol Cell Biol; 2020 May; 21(1):37. PubMed ID: 32404047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.